Dr. Bruce Conklin at the Gladstone Institute of Cardiovascular Disease has posted a "challenge" to the NHLBI Strategic Visioning Initiative titled: "Use isogenic iPS cells to advance Precision Medicine."
Dr. Joseph Wu and colleagues cordially invite you to attend the upcoming Cardiovascular Tissue Engineering Symposium at Stanford. This event, sponsored by the Stanford Cardiovascular Institute, features a number of PCBC investigators and is free of charge to all PCBC members. Please save the date (Friday, May 22nd, 2015) and register at the following website link http://tinyurl.com/cvte2015.
A team led by Ed Morrisey, PhD, a professor of Medicine and Cell and Developmental Biology and the scientific director of the Institute for Regenerative Medicine in the Perelman School of Medicine at the University of Pennsylvania, has now shown that a subset of RNA molecules, called microRNAs, is important for cardiomyocyte cell proliferation during development and is sufficient to induce proliferation in cardiomyocytes in the adult heart.
PCBC Investigator Helen Blau, professor of microbiology and immunology at Stanford University and director of the university's Baxter Laboratory for Stem Cell Biology, and colleagues have published an important discovery toward lengthening telomeres in The Federation of American Societies for Experimental Biology (FASEB) Journal (http://www.fasebj.org).
Gene Uenishi, a graduate student, in Dr. Igor Slukvin’s laboratory under the Thomson Hub Site 02 at the University of Wisconsin – Madison, has recently published an article titled, “Tenascin C Promotes Hematoendothelial Development and T Lymphoid Commitment from Human Pluripotent Stem Cells in Chemically Defined Conditions” in the Stem Cell Reports.